Edition:
United Kingdom

Gemphire Therapeutics Inc (GEMP.OQ)

GEMP.OQ on NASDAQ Stock Exchange Global Market

0.89USD
14 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.89
Open
$0.90
Day's High
$0.98
Day's Low
$0.89
Volume
7,037
Avg. Vol
105,647
52-wk High
$11.41
52-wk Low
$0.83

Chart for

About

Gemphire Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of therapeutics to treat cardiovascular and metabolic diseases. It is developing its product candidate, gemcabene (CI-1027), which is a once-daily, oral therapy for patients who are unable to... (more)

Overall

Beta: --
Market Cap(Mil.): $110.31
Shares Outstanding(Mil.): 10.63
Dividend: --
Yield (%): --

Financials

  GEMP.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -2.65 -- --
ROI: -580.12 9.01 14.96
ROE: -3,285.30 10.15 16.52

Earnings vs. Estimates